Delivery Order SPE2DB22D1002-SPE2DB25FLHW9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,120.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed price delivery order was awarded on a competitive basis with no set-aside designation. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,905.08 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This contract, awarded on August 8, 2025, with a completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $16,566.76 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 12, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $36,331.88 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity: 30 units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement of pharmaceutical supplies for federal medical needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $9,837.09. This is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, utilizing no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $22,737.60 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) under a firm fixed price contract. This delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a non-competitive set-aside award to support federal pharmaceutical procurement needs. The pharmaceutical product will be performed and distributed from AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,442.91 for DESCOVY 200-25 mg tablets in quantities of 30, with a firm fixed price and ultimate completion date of May 28, 2025. This non-set-aside contract was competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a ceiling value of $26,853.37. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 19, 2025, and represents a child contract under a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,203.86 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a continuation of the company's role as a critical supplier within the federal medical supply chain, specifically...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHW9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) valued at $2,301.40 under a firm fixed-price contract. This non-set-aside delivery order, awarded on September 18, 2025, represents a continuation of pharmaceutical supply fulfillment to support federal military and healthcare operations. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency requirements and other federal healthcare systems worldwide. Through competitive procurement processes, AmerisourceBergen has established itself as a critical pharmaceutical distributor for federal medical supply chains, delivering diverse therapeutic products ranging from specialty medications to generic pharmaceuticals across multiple clinical domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/18/25 |